Quarterly report [Sections 13 or 15(d)]

Warrants

v3.26.1
Warrants
 6 Months Ended
Jun. 30, 2026
Warrants  
Warrants

Note 16: Warrants

 

The following table summarizes the activity in the Company’s outstanding warrants during the six months ended June 30, 2026:

                       
    Warrants   Weighted-Average Remaining Contractual Life   Weighted-Average Exercise Price per Share
Outstanding at December 31, 2025     41,622,504       2.86     $ 1.52  
Granted     –       –       –  
Exercised     (1,000,000 )     –       0.57  
Expired     (1,662,500 )     –       23.70  
Forfeitures     –       –       –  
Outstanding at June 30, 2026     38,960,004       2.57     $ 0.60  
                         
Exercisable at June 30, 2026     38,960,004       2.57     $ 0.60  

 

All outstanding warrants are classified as equity instruments in the Company’s condensed consolidated balance sheet, as the warrants meet the criteria for equity classification under ASC 815-40.

 

On June 16, 2026, the Company issued 1,000,000 shares of common stock upon the cash exercise of outstanding warrants at an exercise price of $0.57 per share, resulting in gross proceeds of approximately $0.6 million. The shares were issued in accordance with the terms of the underlying warrant agreements.

 

During the six months ended June 30, 2026, the Company did not grant or forfeit any warrants.